← Evidence map

ArticleDrug design, development and therapy2018

Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure.

Jin Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 30349194